The role of cell-free hemoglobin and haptoglobin in acute kidney injury in critically ill adults with ARDS and therapy with VV ECMO.

导出 OA

翻译打印收藏纠错

作者： Jan A,Graw ^[1] ; Philip,Hildebrandt ^[2] ; Alexander,Krannich ^[3] ; Felix,Balzer ^[4] ; Claudia,Spies ^[5] ; Roland C,Francis ^[6] ; Wolfgang M,Kuebler ^[4] ; Steffen,Weber-Carstens ^[7] ; Mario,Menk ^[4] ; Oliver,Hunsicker ^[7]

作者单位： Department of Anesthesiology and Operative Intensive Care Medicine CCM / CVK, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany. jan-adriaan.graw@charite.de. ^[1] ARDS/ECMO Centrum Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany. jan-adriaan.graw@charite.de. ^[2] Berlin Institute of Health (BIH), Berlin, Germany. jan-adriaan.graw@charite.de. ^[3] Department of Anesthesiology and Operative Intensive Care Medicine CCM / CVK, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin, Germany. ^[4] Clinical Trial Office, Charité - Universitätsmedizin Berlin, Berlin, Germany. ^[5] Institute of Medical Informatics, Charité - Universitätsmedizin Berlin, Berlin, Germany. ^[6] ARDS/ECMO Centrum Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany. ^[7] Institute of Physiology, Charité - Universitätsmedizin Berlin, Berlin, Germany. ^[8]

关键词 ARDS Acute kidney injury Cell-free hemoglobin Haptoglobin